Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jun 15;6(3):256-63.

Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity

Mahssa Karimi  1 , Josef Koranyi, Celina Franco, Yüksel Peker, Derek N Eder, Jan-Erik Angelhed, Lars Lönn, Ludger Grote, Bengt-Ake Bengtsson, Johan Svensson, Jan Hedner, Gudmundur Johannsson
Affiliations
Randomized Controlled Trial

Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity

Mahssa Karimi et al. J Clin Sleep Med. .

Abstract

Background: Risk factors for obstructive sleep apnea (OSA) are male gender, obesity and abnormalities in neck soft tissue mass. OSA is associated with both growth hormone (GH) excess and severe GH deficiency in adults. Adults with abdominal obesity have markedly suppressed GH secretion.

Aim: To study the effect of GH treatment on OSA in abdominally obese men with impaired glucose tolerance.

Patients and methods: Forty men with abdominal obesity and glucose intolerance were randomized in a prospective, 12-month double-blind trial to receive either GH or placebo. The treatment groups had similar BMI and waist circumference. Overnight polysomnography and computed tomography to assess muscle and fat distribution in the neck and abdomen were performed at baseline and after 12 months.

Results: GH treatment increased insulin-like growth-factor-1i from (mean [SD]) 168 (72) to 292 (117) microg/L, the apnea-hypopnea index from (n/h) 31 (20) to 43 (25) and oxygen-desaturation index from (n/h) 18 (14) to 29 (21) (p = 0.0001, 0.001, 0.002). Neck transverse diameter, circumference and total cross-sectional area (p = 0.007, 0.01, 0.02) increased, while abdominal visceral adipose tissue (p = 0.007) was reduced. No between-group differences in total sleep time, REM sleep, NREM sleep, and time spent in supine position were found. The Epworth sleepiness scale score was unchanged.

Conclusions: GH treatment increased the severity of OSA in abdominally obese men. The possible mechanism appears to be reflected by the GH-induced increase of measures of neck volume. The present results, to some extent, argue against that low GH/IGF-I activity is a primary cause of OSA in abdominally obese men.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Top—Sagittal image showing the level of the neck CT scan, in the fourth cervical vertebra and parallel to the third and fourth cervical intervertebral space. Bottom—Cross-sectional area showing laryngo-pharynx, muscle tissue area, subcutaneous adipose tissue (SAT) area and intermuscular adipose tissue (IMAT) area.
Figure 2
Figure 2
Boxplot of AHI pre- and post- GH or placebo (pla) treatment, indicating the lower and upper quartiles (25% and 75%) with the central line indicating the median.
Figure 3
Figure 3
Boxplots of ODI pre- and post- GH or placebo (pla) treatment.
Figure 4
Figure 4
Boxplots of neck transverse diameter pre- and post- GH or placebo (pla) treatment.
See this image and copyright information in PMC

References

    1. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–41. - PubMed
    1. Dostalova S, Sonka K, Smahel Z, Weiss V, Marek J, Horinek D. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur J Endocrinol. 2001;144:491–7. - PubMed
    1. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25:102–52. - PubMed
    1. Hochban W, Ehlenz K, Conradt R, Brandenburg U. Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J. 1999;14:196–202. - PubMed
    1. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 1991;72:51–9. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources